Is Viking Therapeutics Stock Going to $50? Bulls and Bears
A wide-open weight-loss drug market has investors buzzing about Viking Therapeutics. This article breaks down the bul...
Which Funds Beat Active Funds Index helps readers compare strategies and track records, highlighting criteria to identify consistent, low-cost winners.
23,766 articlesA wide-open weight-loss drug market has investors buzzing about Viking Therapeutics. This article breaks down the bul...
Comcast announced a UK broadcaster acquisition just days after revealing NBCUniversal’s spin-off plan, signaling a bo...
Lululemon faced a sharp setback as the year unfolded, leaving investors asking if the brand can recover. This guide b...
NuScale Power has sparked excitement around small modular reactors, but does the hype translate into real investing u...
An investor-oriented deep dive into Lyft's leadership under David Risher and how the MiB framework guides growth, eff...
Two drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
Memory plays a critical role in AI growth, and micron's data center gross margin has surged to industry-leading level...
When CODA reports its Q2 2026 results, the focus shifts from headlines to signals—backlog, margins, and customer wins...
A CFO selling NuScale stock can spark questions about the company’s outlook. This guide breaks down what the move mig...
Fundstrat co-founder Tom Lee points to the ETH/BTC ratio as a sign of a potential leadership shift in crypto, suggest...
Jim Cramer says he cringes at owning AT&T or Verizon as Bernstein flags Starlink competition risk, signaling a potent...
Lucid has wowed investors with fast-paced progress and bold promises. Yet the stock faces real headwinds. Here are th...